Boston Trust Walden Corp Jazz Pharmaceuticals PLC Transaction History
Boston Trust Walden Corp
- $13.8 Billion
- Q2 2025
A detailed history of Boston Trust Walden Corp transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Boston Trust Walden Corp holds 407,897 shares of JAZZ stock, worth $47.6 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
407,897
Previous 178,012
129.14%
Holding current value
$47.6 Million
Previous $22.1 Million
95.86%
% of portfolio
0.31%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding JAZZ
# of Institutions
587Shares Held
60.1MCall Options Held
424KPut Options Held
190K-
Black Rock Inc. New York, NY6.15MShares$717 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$702 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$288 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$271 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$229 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.31B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...